Good ideas and conversation. No ads, no tracking. Login or Take a Tour!
- Last week I wrote a post about new data from BioMedTracker that show that the Food and Drug Administration, which once approved as few as 40% of new drugs submitted by industry, has been on a green-light-almost-everything jag, approving 89% of drug applications.
What’s more, a closer look showed an even higher approval rate. This year so far, 96% of new molecular entities– industry jargon for drugs that have never been approved for any use before – that have been submitted to the FDA have reached the market. For anyone who was watching the FDA a decade ago, that’s just shocking. Good or bad, it’s a radical change.